Providing vaccines against human papillomavirus to adolescent girls in the Americas: battling cervical cancer, improving overall health

Health Aff (Millwood). 2011 Jun;30(6):1089-95. doi: 10.1377/hlthaff.2011.0315.

Abstract

Vaccines against the human papillomavirus (HPV)--the primary cause of cervical cancer--target adolescent girls, many of whom have limited contact with health services. Countries in the Americas are beginning to use HPV vaccines to increase the impact of cervical cancer programs and as an entry point to broader health services for girls. This strategy opens new opportunities to improve lifelong health habits; encourage regular cervical cancer screening and treatment, when necessary; and offer associated services such as reproductive health and nutrition guidance. Some of the early experiences with this strategy illustrate challenges and opportunities that may arise with other new vaccines.

MeSH terms

  • Adolescent
  • Alphapapillomavirus / drug effects
  • Alphapapillomavirus / immunology*
  • Caribbean Region / epidemiology
  • Central America / epidemiology
  • Female
  • Humans
  • Mass Screening / statistics & numerical data
  • North America / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / supply & distribution*
  • South America / epidemiology
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control

Substances

  • Papillomavirus Vaccines